Transgenomic Develops New Assays to Detect EGFR Mutations

Transgenomic, Inc. Monday announced completion of a development study of several new assays to detect genetic mutations using the company’s proprietary co-amplification at Lower Denaturing Temperature PCR technology in the Epidermal Growth Factor Receptor (EGFR) gene.
Earth Times